ACFT Urine Drug Screen

Performed on all samples. Testing requires 30 mL of urine without preservative.

AnalyteUnitsCut-offInstrument/MethodTransportation Conditions
Amphetaminesng/mL500ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Benzodiazepinesng/mL200ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Buprenorphineng/mL10ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Creatininemg/dL20ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Cocaineng/mL150ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
EDDPng/mL300ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Ethanolmg/dL20ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Fentanylng/mL2ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Opiatesng/mL300ImmunoassayRefrigerate or Room Temperature
Stability: 7 days
Oxycodoneng/mL100ImmunoassayRefrigerate or Room Temperature
Stability: 7 days

ACFT Multidrug Panel

Performed on all samples.

Note: alpha-Hydroxyethylbromazolam is currently being monitored, but not reported.

AnalyteUnitsCut-offInstrument/MethodTransportation Conditions
Buprenorphineng/mL10LC-MS/MSN/A
Norbuprenorphineng/mL10LC-MS/MSN/A
Methadoneng/mL300LC-MS/MSN/A
EDDPng/mL300LC-MS/MSN/A
6-Acetylmorphine (6-MAM)ng/mL5LC-MS/MSN/A
Codeineng/mL50LC-MS/MSN/A
Morphineng/mL50LC-MS/MSN/A
Hydrocodoneng/mL50LC-MS/MSN/A
Hydromorphoneng/mL50LC-MS/MSN/A
Oxycodoneng/mL50LC-MS/MSN/A
Noroxycodoneng/mL50LC-MS/MSN/A
Oxymorphoneng/mL50LC-MS/MSN/A
Thebaineng/mL50LC-MS/MSN/A
Tramadolng/mL50LC-MS/MSN/A
O-desmethyl-cis-Tramadolng/mL50LC-MS/MSN/A
Fentanylng/mL5LC-MS/MSN/A
Norfentanylng/mL5LC-MS/MSN/A
Carfentanilng/mL2LC-MS/MSN/A
Norcarfentanilng/mL2LC-MS/MSN/A
ortho-Methylfentanylng/mL5LC-MS/MSN/A
para-Flurofentanylng/mL5LC-MS/MSN/A
Xylazineng/mL50LC-MS/MSN/A
4-Hydroxyxylazineng/mL50LC-MS/MSN/A
Medetomidineng/mL10LC-MS/MSN/A
3-Hydroxymedetomidineng/mL50LC-MS/MSN/A
Ketamineng/mL50LC-MS/MSN/A
Norketamineng/mL50LC-MS/MSN/A
Amphetamineng/mL50LC-MS/MSN/A
Methamphetamineng/mL50LC-MS/MSN/A
MDAng/mL50LC-MS/MSN/A
MDMAng/mL50LC-MS/MSN/A
Benzoylecgonineng/mL100LC-MS/MSN/A
7-Aminoclonazepamng/mL50LC-MS/MSN/A
7-Aminonitrazepamng/mL50LC-MS/MSN/A
alpha-Hydroxyalprazolamng/mL50LC-MS/MSN/A
alpha-Hydroxytriazolamng/mL50LC-MS/MSN/A
Bromazepamng/mL50LC-MS/MSN/A
Bromazolamng/mL50LC-MS/MSN/A
alpha-Hydroxybromazolamng/mL50LC-MS/MSN/A
Demoxepamng/mL50LC-MS/MSN/A
3-Hydroxydesalkylgidazepamng/mL50LC-MS/MSN/A
Diazepamng/mL50LC-MS/MSN/A
Ethylbromazolamng/mL10LC-MS/MSN/A
alpha-Hydroxyethylbromazolamng/mL50LC-MS/MSN/A
Etizolamng/mL50LC-MS/MSN/A
alpha-Hydroxyetizolamng/mL50LC-MS/MSN/A
Flualprazolamng/mL50LC-MS/MSN/A
alpha-Hydroxyflualprazolamng/mL50LC-MS/MSN/A
Flubromazepamng/mL50LC-MS/MSN/A
3-Hydroxyflubromazepamng/mL50LC-MS/MSN/A
alpha-Hydroxyflubromazolamng/mL50LC-MS/MSN/A
Lorazepamng/mL50LC-MS/MSN/A
1-Hydroxymidazolamng/mL50LC-MS/MSN/A
Norclobazamng/mL50LC-MS/MSN/A
Nordiazepamng/mL50LC-MS/MSN/A
Oxazepamng/mL50LC-MS/MSN/A
Temazepamng/mL50LC-MS/MSN/A
Diphenhydramineng/mL50LC-MS/MSN/A
Gabapentinng/mL500LC-MS/MSN/A
Ritalinic acidng/mL500LC-MS/MSN/A
Methylphenidateng/mL100LC-MS/MSN/A
Zolpidemng/mL50LC-MS/MSN/A
Zolpidem Phenyl-4-carboxylic acidng/mL50LC-MS/MSN/A
Zopicloneng/mL50LC-MS/MSN/A
N-desmethylzopicloneng/mL50LC-MS/MSN/A

Confirmatory and Other Testing

Performed as required or as requested.

AnalyteUnitsCut-offInstrument/MethodTransportation Conditions
Ethanolmg/dL20GC-FIDN/A
Glucosemg/dL50 - 100Test StripN/A
Ethyl Glucuronideng/mL250Q-Trap LC-MS/MSRefrigerate or Room Temperature
Stability: 7 days
Ethyl Sulfateng/mL200Q-Trap LC-MS/MSRefrigerate or Room Temperature
Stability: 7 days
Gamma Hydroxybutyrateµg/mL10Q-Trap LC-MS/MSRefrigerate or Room Temperature
Stability: 7 days
NitazenesN/AN/AQ-Exactive
(Qualitative analysis only)
Refrigerate or Room Temperature
Stability: 7 days

Discontinued Testing

AnalyteUnitsCut-offInstrument/MethodDiscontinued Date
Alprazolamng/mL50LC-MS/MSDecember 2024
Clobazamng/mL50LC-MS/MSDecember 2024
Flubromazolamng/mL50LC-MS/MSDecember 2024
Midazolamng/mL50LC-MS/MSDecember 2024
Methadone in serumng/mL50LC-MS/MSOctober 2024
EDDP in serumng/mL50LC-MS/MSOctober 2024
alberta centre for toxicology